Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA2A | P29274 | 13/20 | 0.58 |
| ▸ | PGK1 | P00558 | 3/20 | 0.49 |
| ▸ | PGK2 | P07205 | 3/20 | 0.49 |
| ▸ | ADORA3 | P0DMS8 | 5/20 | 0.48 |
| ▸ | NT5E | P21589 | 1/20 | 0.45 |
| ▸ | ADORA2B | P29275 | 2/20 | 0.45 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7594742 | 1.00 | ADORA2A (0.58) | ADORA2APGK1PGK2ADORA3NT5E | |
| SCHEMBL6839057 | 1.00 | ADORA2A (0.58) | ADORA2APGK1PGK2ADORA3NT5E | |
| SCHEMBL7595603 | 0.94 | PGK1 (0.57) | ADORA2APGK1PGK2ADORA3ADORA2B | |
| SCHEMBL6839113 | 0.94 | PGK1 (0.57) | ADORA2APGK1PGK2ADORA3ADORA2B | |
| SCHEMBL6839831 | 0.93 | ADORA3 (0.54) | ADORA2AADORA3ADORA2BADORA1 | |
| SCHEMBL6839042 | 0.90 | ADORA2A (0.72) | ADORA2AADORA3ADORA2BADORA1 | |
| SCHEMBL6839796 | 0.90 | ADORA2A (0.72) | ADORA2AADORA3ADORA2BADORA1 | |
| SCHEMBL7598658 | 0.89 | ADORA2A (0.54) | ADORA2APGK1PGK2ADORA3ADORA2B | |
| SCHEMBL7598650 | 0.89 | ADORA2A (0.54) | ADORA2APGK1PGK2ADORA3ADORA2B | |
| SCHEMBL6838990 | 0.89 | ADORA2A (0.54) | ADORA2APGK1PGK2ADORA3ADORA2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1051425-B1 | 2-(PURIN-9-yl)-TETRAHYDROFURAN-3,4-DIOL DERIVATIVES | GLAXO GROUP LTD (GB) | 2002-10-30 | — | — | EP | claimed |